Viewing Study NCT02077634


Ignite Creation Date: 2025-12-25 @ 2:18 AM
Ignite Modification Date: 2025-12-27 @ 11:58 PM
Study NCT ID: NCT02077634
Status: COMPLETED
Last Update Posted: 2020-03-18
First Post: 2013-12-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Trial of Abiraterone Acetate Plus LHRH-therapy Versus Abiraterone Acetate Sparing LHRH-therapy in Patients With Progressive Chemotherapy-naïve Castration-resistant Prostate Cancer (SPARE)
Sponsor: Universität des Saarlandes
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module